US2004247523A1PendingUtilityA1
Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
Assignee: BRISTOL MYERS SQUIBB PHARMA COPriority: Nov 3, 2000Filed: Jun 10, 2004Published: Dec 9, 2004
Est. expiryNov 3, 2020(expired)· nominal 20-yr term from priority
Inventors:Alan P. Carpenter, Jr.
A61K 51/0497A61K 51/12
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides novel diagnostic compositions comprising a radiolabeled LTB4 binding agent and a radiolabeled perfusion imaging agent, diagnostic kits comprising such compositions, and methods of concurrent imaging in a mammal comprising administering a radiolabeled LTB4 binding agent and a radiolabeled perfusion imaging agent, and concurrently detecting the radiolabeled LTB4 binding agent bound at the LTB4 receptor and the radiolabeled perfusion imaging agent.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of diagnosing and localizing sites of inflammation and perfusion abnormalities in a single dual isotope imaging procedure.
2 . A method of diagnostic imaging comprising the concurrent detection and localization of sites of ischemic tissue injury and perfusion abnormalities in a single imaging procedure.
3 . A method according to claim 2 , wherein the imaging procedure is one or more procedure selected from the group, CT imaging, ultrasound, and scintigraphy.
4 . A method of diagnosing and localizing sites of inflammation and perfusion abnormalities in a single dual imaging procedure.
5 . A method according to claim 4 , wherein the imaging procedure is one or more procedure selected from the group, CT imaging, ultrasound, and scintigraphy.
6 . A method of diagnostic imaging comprising the concurrent detection and localization of sites of of ischemic tissue injury (e.g. reperfusion injury), vulnerable plaque, bacterial endocarditis or cardiac transplant rejection in a single dual imaging procedure.
7 . A method according to claim 6 , wherein the imaging procedure is one or more procedure selected from the group, CT imaging, ultrasound, and scintigraphy.
8 . A method of diagnostic imaging comprising the concurrent detection and localization of sites of vulnerable plaque and perfusion abnormalities in a single imaging procedure.
9 . A method according to claim 8 , wherein the imaging procedure is one or more procedure selected from the group, CT imaging, ultrasound, and scintigraphy.
10 . A method of diagnostic imaging comprising the concurrent detection and localization of sites of cardiac infection and perfusion abnormalities in a single imaging procedure.
11 . A method according to claim 10 , wherein the imaging procedure is one or more procedure selected from the group, CT imaging, ultrasound, and scintigraphy.
12 . A method of diagnostic imaging comprising the concurrent detection and localization of sites of cardiac transplant rejection and perfusion abnormalities in a single imaging procedure.
13 . A method according to claim 12 , wherein the imaging procedure is one or more procedure selected from the group, CT imaging, ultrasound, and scintigraphy.Join the waitlist — get patent alerts
Track US2004247523A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.